Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Pharm Stat. 2014 Nov 19;14(2):82–94. doi: 10.1002/pst.1661

Table A.1.

Abbreviations used in the text.

Abbreviation Full text

ABE average bioequivalence
AUC area under the blood concentration-time curve
BE bioequivalence
BIE bioinequivalence
Cmax peak concentration
CI confidence interval
CV coefficient of variation
EMA European Medicines Agency
FDA The United States Food and Drug Administration
GLL generalized law of likelihood
GLR generalized likelihood ratio
GMR geometric mean ratio
HVD highly variable drug
IBE individual bioequivalence
LI likelihood interval
MLE maximum likelihood estimate
PBE population bioequivalence
RSABE reference scaled average bioequivalence
TOST Two-One-Sided-Tests